FORTAZ Side Effects

6243739-8 | Rash
on Jul 16, 2008 Male patient from UNITED STATES , 47 years of age, was treated with Fortaz (View Usage). Patient experienced the following unwanted or unexpected effects: rash (What is rash?). Fortaz dosage: .

6243738-6 | Hepatic Enzyme Increased
Patient was taking Fortaz (View Usage). Patient had the following side effects: hepatic enzyme increased on Jul 18, 2008 from UNITED STATES Additional patient health information: Male patient , 22 years of age, weighting 97.22 lb, was diagnosed with pneumonia (What is pneumonia?) and. Fortaz dosage: 1g Three Times Per Day. During the same period patient was treated with TYLENOL (CAPLET) (650mg As Required) (View Tylenol (caplet) Review and Tylenol (caplet) Label ), DUONEB (3ml As Required) (View Duoneb Review and Duoneb Label ), BACLOFEN (20mg Four Times Per Day) (View Baclofen Review and Baclofen Label ), LOVENOX (30mg Twenty Four Times Per Day) (View Lovenox Review and Lovenox Label ), FENTANYL (12mcg Every 3 Days) (View Fentanyl Review and Fentanyl Label ), PREVACID (30mg Per Day) (View Prevacid Review and Prevacid Label ), ATIVAN (1mg As Required) (View Ativan Review and Ativan Label ), LOPRESSOR (25mg Twice Per Day) (View Lopressor Review and Lopressor Label ).

6161870-2 | Depressed Level Of Consciousness, Heart Rate Increased, Staring
Adverse event was reported on Apr 15, 2009 by a Male patient taking Fortaz (View Usage) (Dosage: ) . Location: UNITED STATES , 21 years of age, After Fortaz was administered, patient had the following side effects: depressed level of consciousness, heart rate increased, staring. During the same period patient was treated with FERRLECIT (View Ferrlecit Review and Ferrlecit Label ), VANCOMYCIN HCL (View Vancomycin Hcl Review and Vancomycin Hcl Label ).

5901996-9 | Pyrexia, Rash
on May 02, 2007 Male patient from UNITED STATES , 14 years of age, was treated with Fortaz (View Usage). Patient experienced the following unwanted or unexpected effects: pyrexia, rash (What is rash?). Fortaz dosage: . During the same period patient was treated with CEFAZOLIN (View Cefazolin Review and Cefazolin Label ), DIANEAL (View Dianeal Review and Dianeal Label ).


5793560-X | Extravasation, Infusion Site Irritation
on Dec 10, 2007 Female patient from UNITED STATES , 40 years of age, was diagnosed with pneumonia (What is pneumonia?) and was treated with Fortaz (View Usage). Patient had the following side effects: extravasation, infusion site irritation. Fortaz dosage: . During the same period patient was treated with PERCOCET (View Percocet Review and Percocet Label ), ATIVAN (View Ativan Review and Ativan Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), PHENERGAN HCL (View Phenergan Hcl Review and Phenergan Hcl Label ).

5692962-X | Injection Site Infection, Injection Site Mass
Patient was taking Fortaz (View Usage). After Fortaz was administered, patient had the following side effects: injection site infection, injection site mass on Apr 02, 2008 from UNITED STATES Additional patient health information: Female patient , weighting 140.0 lb, was diagnosed with osteoporosis (What is osteoporosis?) and. Fortaz dosage: Metered Doses Of Date Sq. During the same period patient was treated with ROCEPHIN (View Rocephin Review and Rocephin Label ), LEVAQUIN (View Levaquin Review and Levaquin Label ), BACTRIM (View Bactrim Review and Bactrim Label ), TETRACYCLINE (View Tetracycline Review and Tetracycline Label ). Patient was hospitalized.

5644111-1 | Renal Failure
Adverse event was reported on Feb 12, 2008 by a Female patient taking Fortaz (View Usage) (Dosage: 1 Gram(s) / Three Times Per Day / Oral) . Location: FRANCE , 68 years of age, Patient experienced the following unwanted or unexpected effects: renal failure. During the same period patient was treated with GENTAMICIN SULFATE (80 Mg / Twice Per Day / Oral) (View Gentamicin Sulfate Review and Gentamicin Sulfate Label ), VALACICLOVIR HYDROCHLORID (View Valaciclovir Hydrochlorid Review and Valaciclovir Hydrochlorid Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), HEPARIN CALCIUM (View Heparin Calcium Review and Heparin Calcium Label ), ME PREDNISOLONE NA SUCC. (View Me-prednisolone Na Succ. Review and Me-prednisolone Na Succ. Label ). Patient was hospitalized.

5639926-X | Blood Alkaline Phosphatase Increased, Gamma-glutamyltransferase Increased, Leukaemia Recurrent, Pancreatitis Acute
on Feb 11, 2008 Male patient from FRANCE , 21 years of age, was diagnosed with acute myeloid leukaemia and was treated with Fortaz (View Usage). Patient had the following side effects: blood alkaline phosphatase increased, gamma-glutamyltransferase increased, leukaemia recurrent, pancreatitis acute. Fortaz dosage: Intravenous. During the same period patient was treated with ZOFRAN (Oral) (View Zofran Review and Zofran Label ), CYTARABINE (1.8 Gram(s)/twice Per Day/intravenous) (View Cytarabine Review and Cytarabine Label ), MITOXANTRONE HCL (21 Mg/per Day/intravenous) (View Mitoxantrone Hcl Review and Mitoxantrone Hcl Label ), CIFLOX INJECTION (CIFLOX) (500 Mg/twice Per Day/intravenous) (View Ciflox Injection (ciflox) Review and Ciflox Injection (ciflox) Label ), URATE OXIDASE INJECTION (RASBURICASE) (Intravenous) (View Urate Oxidase Injection (rasburicase) Review and Urate Oxidase Injection (rasburicase) Label ), GEMTUZUMAB OZOGAMICIN INJECTION (GEMTUZUMAB OZOGAMICIN) (Intravenous) (View Gemtuzumab Ozogamicin Injection (gemtuzumab Ozogamicin) Review and Gemtuzumab Ozogamicin Injection (gemtuzumab Ozogamicin) Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ). Patient was hospitalized.

5639763-6 | Confusional State
on Feb 13, 2008 Female patient from SPAIN , 71 years of age, was diagnosed with pseudomonas infection and was treated with Fortaz (View Usage). After Fortaz was administered, patient had the following side effects: confusional state. Fortaz dosage: Three Times Per Day / Intra. Patient was hospitalized.

5636221-X | Pruritus, Rash
Patient was taking Fortaz (View Usage). Patient experienced the following unwanted or unexpected effects: pruritus, rash (What is rash?) on Feb 20, 2008 from UNITED STATES Additional patient health information: Female patient , 61 years of age, weighting 136.0 lb, was diagnosed with evidence based treatment, diarrhoea and. Fortaz dosage: 1 Gram Q8h Iv. During the same period patient was treated with FLAGYL (500 Mg Tid Peg) (View Flagyl Review and Flagyl Label ).

5625479-9 | Blood Culture Positive, Contusion, Ecthyma, Gangrene, Klebsiella Infection, Lethargy, Pseudomonas Infection, Staphylococcal Infection
Adverse event was reported on Jan 24, 2008 by a Female patient taking Fortaz (View Usage) (Dosage: ) was diagnosed with acute myeloid leukaemia and. Location: UNITED STATES , 48 years of age, Patient had the following side effects: blood culture positive, contusion, ecthyma, gangrene, klebsiella infection, lethargy, pseudomonas infection, staphylococcal infection (What is staphylococcal infection?). During the same period patient was treated with DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ), GENTAMICIN SULFATE (View Gentamicin Sulfate Review and Gentamicin Sulfate Label ), AMIKACIN (View Amikacin Review and Amikacin Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), TRETINOIN (View Tretinoin Review and Tretinoin Label ). Patient was hospitalized.

5584035-1 | Cardiac Valve Vegetation, Pancytopenia, Post Procedural Complication
on Jan 04, 2008 Male patient from UNITED STATES , 69 years of age, was treated with Fortaz (View Usage). After Fortaz was administered, patient had the following side effects: cardiac valve vegetation, pancytopenia, post procedural complication. Fortaz dosage: . During the same period patient was treated with ZYVOX (View Zyvox Review and Zyvox Label ).

5486039-6 | Agranulocytosis, Haemoglobin Decreased, Platelet Count Decreased, Sepsis, White Blood Cell Count Decreased
on Oct 01, 2007 Female patient from FRANCE , 40 years of age, was treated with Fortaz (View Usage). Patient experienced the following unwanted or unexpected effects: agranulocytosis, haemoglobin decreased, platelet count decreased, sepsis (What is sepsis?), white blood cell count decreased. Fortaz dosage: Intravenous. During the same period patient was treated with RANITIDINE HYDROCHLORIDE (View Ranitidine Hydrochloride Review and Ranitidine Hydrochloride Label ). Patient was hospitalized.

5419499-7 | Pruritus
Patient was taking Fortaz (View Usage). Patient had the following side effects: pruritus on Aug 17, 2007 from UNITED STATES Additional patient health information: Female patient , weighting 150.4 lb, was diagnosed with staphylococcal infection (What is staphylococcal infection?) and. Fortaz dosage: 1 Gram Every 8 Hours Iv.

5374510-7 | Skin Odour Abnormal
Adverse event was reported on Jan 29, 2007 by a Female patient taking Fortaz (View Usage) (Dosage: 2g Four Times Per Day) . Location: UNITED STATES , 52 years of age, After Fortaz was administered, patient had the following side effects: skin odour abnormal.

5300027-1 | Cerebral Calcification, Encephalopathy, Ischaemia
on Apr 04, 2007 Male patient from FRANCE , 77 years of age, was diagnosed with pseudomonas infection and was treated with Fortaz (View Usage). Patient experienced the following unwanted or unexpected effects: cerebral calcification, encephalopathy, ischaemia. Fortaz dosage: Unk / Unk / Intravenous. During the same period patient was treated with CIPROFLOXACIN HCL (View Ciprofloxacin Hcl Review and Ciprofloxacin Hcl Label ), MIDAZOLAM HYDROCHLORIDE (View Midazolam Hydrochloride Review and Midazolam Hydrochloride Label ), SUFENTANIL CITRATE (View Sufentanil Citrate Review and Sufentanil Citrate Label ), AMIKACIN (View Amikacin Review and Amikacin Label ), PIPERACILLIN SODIUM (View Piperacillin Sodium Review and Piperacillin Sodium Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ), URAPIDIL (View Urapidil Review and Urapidil Label ), NICARDIPINE HYDROCHLORIDE (View Nicardipine Hydrochloride Review and Nicardipine Hydrochloride Label ). Patient was hospitalized.

5299922-1 | Convulsion, Hallucination
on Mar 30, 2007 Female patient from JAPAN , 38 years of age, weighting 92.40 lb, was diagnosed with peritonitis and was treated with Fortaz (View Usage). Patient had the following side effects: convulsion, hallucination. Fortaz dosage: 1 Gram (s) Intraperitoneal. During the same period patient was treated with CEFOTIAM HYDROCHLORIDE (View Cefotiam Hydrochloride Review and Cefotiam Hydrochloride Label ), IMIDAPRIL HYDROCHLORIDE (View Imidapril Hydrochloride Review and Imidapril Hydrochloride Label ), NIFEDIPINE (View Nifedipine Review and Nifedipine Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), CALCIUM CARBONATE (View Calcium Carbonate Review and Calcium Carbonate Label ). Patient was hospitalized.

5097750-3 | Blood Creatine Increased, Blood Urea Increased, Dementia, Disorientation, Electroencephalogram Abnormal, Haemodialysis, Loss Of Consciousness, Myoclonus
Patient was taking Fortaz (View Usage). After Fortaz was administered, patient had the following side effects: blood creatine increased, blood urea increased, dementia (What is dementia?), disorientation, electroencephalogram abnormal, haemodialysis, loss of consciousness, myoclonus on Aug 10, 2006 from CHINA Additional patient health information: Female patient , 76 years of age, . Fortaz dosage: See Dosage Text.

5081658-3 | Accidental Overdose, Asterixis, Blood Creatinine Increased, Depressed Level Of Consciousness, Haemodialysis, Lacunar Infarction, Mutism, Nystagmus, Status Epilepticus
Adverse event was reported on Jul 31, 2006 by a Female patient taking Fortaz (View Usage) (Dosage: See Dosage Text) was diagnosed with peritonitis and. Location: THAILAND , 70 years of age, Patient experienced the following unwanted or unexpected effects: accidental overdose, asterixis, blood creatinine increased, depressed level of consciousness, haemodialysis, lacunar infarction, mutism, nystagmus, status epilepticus. Patient was hospitalized.

4959525-2 | Convulsion, Dyskinesia, Hallucination, Muscle Contractions Involuntary
on Mar 27, 2006 Female patient from UNITED STATES , 62 years of age, was diagnosed with skin infection and was treated with Fortaz (View Usage). Patient had the following side effects: convulsion, dyskinesia, hallucination, muscle contractions involuntary. Fortaz dosage: . During the same period patient was treated with DIALYSIS (View Dialysis Review and Dialysis Label ).

4943627-0 | Abdominal Distension, Ascites, Clostridium Colitis, Gastrointestinal Oedema, Hypotension, Multi-organ Failure, Pleural Effusion, Tachycardia, Tachypnoea
on Feb 28, 2006 Female patient from JAPAN , 31 years of age, was treated with Fortaz (View Usage). After Fortaz was administered, patient had the following side effects: abdominal distension, ascites, clostridium colitis, gastrointestinal oedema, hypotension, multi-organ failure, pleural effusion, tachycardia, tachypnoea. Fortaz dosage: Intravenous. During the same period patient was treated with CEFCAPENE PIVOXIL HCL (CEFCAPENE PIVOXIL HCL) (View Cefcapene Pivoxil Hcl (cefcapene Pivoxil Hcl) Review and Cefcapene Pivoxil Hcl (cefcapene Pivoxil Hcl) Label ), CLINDAMYCIN (View Clindamycin Review and Clindamycin Label ), BETAMIPRON + PANIPENEM (BETAMIPRON + PANIPENEM) (View Betamipron + Panipenem (betamipron + Panipenem) Review and Betamipron + Panipenem (betamipron + Panipenem) Label ). Patient was hospitalized.

4939882-3 | Meningitis Aseptic
Patient was taking Fortaz (View Usage). Patient experienced the following unwanted or unexpected effects: meningitis aseptic on Aug 01, 1995 from UNITED STATES Additional patient health information: Female patient , 66 years of age, was diagnosed with infection prophylaxis and. Fortaz dosage: . During the same period patient was treated with CEFAZOLIN (View Cefazolin Review and Cefazolin Label ), CEPHALEXIN (View Cephalexin Review and Cephalexin Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ). Patient was hospitalized.

4883242-0 | Asterixis, Asthenia, Myoclonus
Adverse event was reported on Jan 17, 2006 by a Female patient taking Fortaz (View Usage) (Dosage: 2 Grams Q 8 H Iv Drip) was diagnosed with osteomyelitis, pseudomonas infection and. Location: UNITED STATES , 78 years of age, weighting 210.0 lb, Patient had the following side effects: asterixis, asthenia, myoclonus. During the same period patient was treated with NOVOLIN INSULIN (View Novolin Insulin Review and Novolin Insulin Label ), AMARYL3 (View Amaryl3 Review and Amaryl3 Label ), ARIMIDEX (View Arimidex Review and Arimidex Label ), CELEBREX (View Celebrex Review and Celebrex Label ), NIFEREX (View Niferex Review and Niferex Label ), LANTUS (View Lantus Review and Lantus Label ), LEXAPRO (View Lexapro Review and Lexapro Label ). Patient was hospitalized.

4862521-7 | Clostridium Colitis, Renal Failure, Renal Function Test Abnormal
on Oct 18, 1993 Female patient from UNITED STATES , 61 years of age, was diagnosed with urosepsis, hypertension, atrial fibrillation (What is atrial fibrillation?) and was treated with Fortaz (View Usage). After Fortaz was administered, patient had the following side effects: clostridium colitis, renal failure, renal function test abnormal. Fortaz dosage: 500mg Twice Per Day. During the same period patient was treated with GENTAMICIN (80mg Per Day) (View Gentamicin Review and Gentamicin Label ), LASIX (80mg Three Times Per Day) (View Lasix Review and Lasix Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), VANCERIL (View Vanceril Review and Vanceril Label ), ATROVENT (View Atrovent Review and Atrovent Label ), CAPTOPRIL (50mg Three Times Per Day) (View Captopril Review and Captopril Label ), VERAPAMIL (120mg Three Times Per Day) (View Verapamil Review and Verapamil Label ), HEPARIN (5000unit Twice Per Day) (View Heparin Review and Heparin Label ). Patient was hospitalized and became disabled.

4765393-4 | Infusion Related Reaction, Rash
on Sep 08, 2005 Male patient from UNITED STATES , weighting 212.0 lb, was diagnosed with pneumonia (What is pneumonia?) and was treated with Fortaz (View Usage). Patient experienced the following unwanted or unexpected effects: infusion related reaction, rash (What is rash?). Fortaz dosage: 1 Gram Every 8 Hours Iv. Patient was hospitalized.

4733072-5 | Rash Erythematous
Patient was taking Fortaz (View Usage). Patient had the following side effects: rash erythematous on Aug 01, 2005 from UNITED STATES Additional patient health information: Female patient , 56 years of age, weighting 83.78 lb, was diagnosed with lung infection pseudomonal and. Fortaz dosage: 1 Gram Iv. During the same period patient was treated with VANCOMYCIN (View Vancomycin Review and Vancomycin Label ).

4702414-9 | Infusion Site Reaction, Injection Site Haemorrhage, Injection Site Swelling
Adverse event was reported on Dec 10, 2004 by a Female patient taking Fortaz (View Usage) (Dosage: 2g Three Times Per Day) was diagnosed with pneumonia (What is pneumonia?) and. Location: , 26 years of age, weighting 134.5 lb, After Fortaz was administered, patient had the following side effects: infusion site reaction, injection site haemorrhage, injection site swelling. During the same period patient was treated with ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), ACETAZOLAMIDE (View Acetazolamide Review and Acetazolamide Label ), VALPROIC ACID (View Valproic Acid Review and Valproic Acid Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ), PREVACID (View Prevacid Review and Prevacid Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), OLANZAPINE (View Olanzapine Review and Olanzapine Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ).

4702413-7 | Anaemia, Neutropenia, White Blood Cell Count Decreased
on Sep 14, 2004 Male patient from , child 10 years of age, weighting 73.19 lb, was diagnosed with pseudomonas infection and was treated with Fortaz (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, neutropenia, white blood cell count decreased. Fortaz dosage: 2g Three Times Per Day. During the same period patient was treated with MOTRIN (View Motrin Review and Motrin Label ), HEPARIN (View Heparin Review and Heparin Label ), NORMAL SALINE (View Normal Saline Review and Normal Saline Label ).

4690640-7 | Erythema, Hypersensitivity, Swelling, Urticaria
on May 25, 2005 Male patient from , 13 years of age, weighting 109.1 lb, was diagnosed with urinary tract infection (What is urinary tract infection?) and was treated with Fortaz (View Usage). Patient had the following side effects: erythema, hypersensitivity, swelling, urticaria. Fortaz dosage: . During the same period patient was treated with DITROPAN XL (15mg Per Day) (View Ditropan Xl Review and Ditropan Xl Label ). Patient was hospitalized.

4647702-X | Urticaria
Patient was taking Fortaz (View Usage). After Fortaz was administered, patient had the following side effects: urticaria on Apr 27, 2005 from Additional patient health information: Male patient , weighting 145.5 lb, was diagnosed with arthritis infective and. Fortaz dosage: 2g Iv Q 8 Hrs.

4621477-2 | Procedural Complication
Adverse event was reported on Mar 16, 2005 by a Female patient taking Fortaz (View Usage) (Dosage: Subconjunctival) was diagnosed with endophthalmitis and. Location: , 78 years of age, Patient experienced the following unwanted or unexpected effects: procedural complication.

4559182-3 | Atrioventricular Block First Degree, Blood Pressure Systolic Increased, Dyspnoea, Palpitations, Respiratory Rate Increased, Sinus Arrhythmia, Tachycardia
on Jan 21, 2005 Female patient from , 61 years of age, weighting 121.3 lb, was diagnosed with lung infection pseudomonal and was treated with Fortaz (View Usage). Patient had the following side effects: atrioventricular block first degree, blood pressure systolic increased, dyspnoea, palpitations, respiratory rate increased, sinus arrhythmia, tachycardia. Fortaz dosage: 2 Gram Every 12 Hours Intravenou. During the same period patient was treated with SEREVENT (View Serevent Review and Serevent Label ), PULMICORT (View Pulmicort Review and Pulmicort Label ), GLUCOSAMINE (View Glucosamine Review and Glucosamine Label ), ACIDOPHILUS + MVT (View Acidophilus + Mvt Review and Acidophilus + Mvt Label ), FLONASE (View Flonase Review and Flonase Label ).